The effect of etoricoxib on the pharmacokinetics of oral contraceptives in healthy participants.

scientific article published on 14 May 2009

The effect of etoricoxib on the pharmacokinetics of oral contraceptives in healthy participants. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1177/0091270009337131
P8608Fatcat IDrelease_hpxjxmd7hfhn5bjmymynubh5we
P698PubMed publication ID19443681

P2093author name stringKeith Gottesdiener
Anish Mehta
Thomas Hunt
Patrick Larson
William B Smith
Peggy Wong
Nancy Agrawal
Tami Crumley
Jules Schwartz
P2860cites workInteractions Between Oral Contraceptives and Antifungals/AntibacterialsQ22305836
Single- and multiple-dose pharmacokinetics of etoricoxib, a selective inhibitor of cyclooxygenase-2, in man.Q34183755
Oral contraceptives and the risk of venous thrombosisQ34253607
Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteersQ35802558
Pharmacokinetic drug interactions involving 17alpha-ethinylestradiol: a new look at an old drugQ36718456
Oral contraceptives use and the risk of myocardial infarction: a meta-analysisQ39130555
In vitro metabolism considerations, including activity testing of metabolites, in the discovery and selection of the COX-2 inhibitor etoricoxib (MK-0663).Q43591309
P433issue7
P921main subjectpharmacokineticsQ323936
P304page(s)807-815
P577publication date2009-05-14
P1433published inThe Journal of Clinical PharmacologyQ7743562
P1476titleThe effect of etoricoxib on the pharmacokinetics of oral contraceptives in healthy participants.
P478volume49

Reverse relations

cites work (P2860)
Q34466689Etoricoxib and the treatment of ankylosing spondylitis
Q34610283Etoricoxib: a review of its use in the symptomatic treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute gouty arthritis
Q38880368Prevalence of Non-Cytochrome P450-Mediated Metabolism in Food and Drug Administration-Approved Oral and Intravenous Drugs: 2006-2015.

Search more.